Jan 14, 2025 | Administrative Law, False Claims Act, Fraud Investigations, Health Care, Health Care Fraud
Late last year, President Biden signed the annual National Defense Authorization Act (NDAA) for fiscal year 2025. This alone is not newsworthy, as this has happened every year since the NDAA was introduced in 1961. Generally speaking, the NDAA governs Department of...
Jan 8, 2025 | False Claims Act, Fraud Investigations
Although False Claims Act cases involving federal grant fraud may not be as common as those involving healthcare fraud, the consequences of such cases can be just as significant. Recently, Athira Pharma, a Washington state-based biopharmaceutical company, agreed to...
Nov 11, 2024 | Health Care, Medicare and Medicaid
When the Affordable Care Act was passed and signed into law by President Obama in 2010, one of its provisions required Medicare providers and suppliers to report and refund Medicare overpayments within 60 days of “identifying” such an overpayment. Violating this...
Oct 14, 2024 | False Claims Act, Health Care, Health Care Fraud, White Collar Crime
On October 10, 2024, the DOJ announced that Teva Pharmaceuticals had agreed to pay $450 million to resolve two matters, one of which was the result of an investigation conducted pursuant to the False Claims Act (FCA). According to the DOJ, the settlement encompasses...
Sep 15, 2024 | DOJ, False Claims Act, Fraud Investigations, Health Care, Medicare and Medicaid
Late last week, the Department of Justice announced that Walgreen had agreed to pay over $106 million to resolve allegations that it violated the False Claims Act by billing government health care programs for prescriptions that were never dispensed. According to the...
